Slideshow

Antipsychotics-To Respond or Not to Respond?

Author(s):

Brian Miller, MD, PhD, MPH

A new study brings us closer to answering why antipsychotics are successful in treating schizophrenia in some patients and not in others.

Related Videos
schizophrenia
sc
schizophrenia
clozapine
brain
cognition
clock
clozapine
steering wheel
schizophrenia
Related Content
brain
May 12th 2025

Phase 3 Development Plan for Evenamide as Add-On Therapy for Treatment-Resistant Schizophrenia

Leah Kuntz
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
dawn
May 7th 2025

The Dawn of a New Era for Schizophrenia

Mike Hennessy Jr
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
schizophrenia
April 22nd 2025

Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial

Leah Kuntz
pharmacist
April 16th 2025

Treating Schizophrenia: Bringing Together Pharmacists and Clinicians for Patient Care

Michael McGuire, PharmD
© 2025 MJH Life Sciences

All rights reserved.